Evidence map›Paper›PMID 41184570›Full record

ArticleMolecular psychiatry2026

Altered acetylcholine modulations and corticoaccumbal pathway in P11-linked social dysfunction.

Daniel Dautan, Anderson Camargo, Niclas Branzell, Valentina I Brioschi, Daniel Doyon, Elisa Covatta, Roberta Marongiu, Michael Kaplitt, Karima Chergui, Xiaoqun Zhang and 1 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel DautanDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. daniel.dautan@ki.se.ORCID http://orcid.org/0000-0003-1001-5727
Anderson CamargoDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Niclas BranzellDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0009-0009-3472-6903
Valentina I BrioschiDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Daniel DoyonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Elisa CovattaDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Roberta MarongiuDepartment of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-7609-7000
Michael KaplittDepartment of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA.
Karima CherguiDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-5702-0422
Xiaoqun ZhangDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-9461-8682
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. per.svenningsson@ki.se.ORCID http://orcid.org/0000-0001-6727-3802

Funding

Forskningsrådet om Hälsa, Arbetsliv och Välfärd (Swedish Research Council for Health, Working Life and Welfare) 2019-01422
6 · The paper itself

Abstract

Social relationships rely on the willingness to interact with others and the ability to interpret their emotional cues. Major depressive disorder (MDD) often leads to dysfunctional social interactions, marked by reduced social motivation and difficulties in recognizing emotions, yet these issues remain inadequately explored despite their significant impact on quality of life. These social behaviors, interconnected through the corticoaccumbal pathway, balance anxiety and social interaction, but the underlying mechanisms remain poorly understood. Notably, the calcium-binding protein S100A10 (also known as P11), which is dysregulated in MDD patients and influences the response to antidepressants, is prominently expressed in brain structures involved in social and emotional processing. Here, we demonstrate that chronic restraint stress alters P11 expression along the corticoaccumbal circuit. Additionally, our genetic model, P11-knockout mice, exhibit depression-like behavior, including a reduction of social motivation and impaired recognition of conspecific emotions. Using in vivo and ex vivo electrophysiology, we reveal that P11 expression modulates the response of the corticoaccumbal pathway, influencing the balance between anxiety and social interaction, as well as emotion recognition by regulating dopamine and acetylcholine release in the accumbens. Interestingly, we pinpoint the role of different cholinergic structures in anxiety, social motivation, and emotion recognition. Finally, we show that the prosocial compound oxytocin and social buffering therapy were able to rescue the socially impaired behaviors following chronic stress or P11 ablation, opening new avenues for potential treatments.

Indexed as

AcetylcholineS100 ProteinsAnimalsAnxietyBrainCerebral CortexDepressionDisease Models, AnimalDopamineEmotionsMajor Depressive DisorderMaleMiceMice, Inbred C57BLMice, KnockoutMotivationAcetylcholineDopamineS100 Proteins

Identifiers

PMID41184570
PMCPMC12916318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.